[go: up one dir, main page]

CN111296729A - A kind of water-soluble astaxanthin product and preparation method thereof - Google Patents

A kind of water-soluble astaxanthin product and preparation method thereof Download PDF

Info

Publication number
CN111296729A
CN111296729A CN202010097080.2A CN202010097080A CN111296729A CN 111296729 A CN111296729 A CN 111296729A CN 202010097080 A CN202010097080 A CN 202010097080A CN 111296729 A CN111296729 A CN 111296729A
Authority
CN
China
Prior art keywords
astaxanthin
water
solution
whey
soluble
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN202010097080.2A
Other languages
Chinese (zh)
Other versions
CN111296729B (en
Inventor
江虹鋭
王富云
王成财
王哲銘
梁舒韵
刘小玲
李树波
姜毅
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Guangxi University
Original Assignee
Guangxi University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guangxi University filed Critical Guangxi University
Priority to CN202010097080.2A priority Critical patent/CN111296729B/en
Publication of CN111296729A publication Critical patent/CN111296729A/en
Application granted granted Critical
Publication of CN111296729B publication Critical patent/CN111296729B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L5/00Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
    • A23L5/40Colouring or decolouring of foods
    • A23L5/42Addition of dyes or pigments, e.g. in combination with optical brighteners
    • A23L5/43Addition of dyes or pigments, e.g. in combination with optical brighteners using naturally occurring organic dyes or pigments, their artificial duplicates or their derivatives
    • A23L5/44Addition of dyes or pigments, e.g. in combination with optical brighteners using naturally occurring organic dyes or pigments, their artificial duplicates or their derivatives using carotenoids or xanthophylls
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23BPRESERVATION OF FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; CHEMICAL RIPENING OF FRUIT OR VEGETABLES
    • A23B2/00Preservation of foods or foodstuffs, in general
    • A23B2/90Preservation of foods or foodstuffs, in general by drying or kilning; Subsequent reconstitution
    • A23B2/92Freeze drying
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23BPRESERVATION OF FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; CHEMICAL RIPENING OF FRUIT OR VEGETABLES
    • A23B2/00Preservation of foods or foodstuffs, in general
    • A23B2/90Preservation of foods or foodstuffs, in general by drying or kilning; Subsequent reconstitution
    • A23B2/93Spray drying
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115Fatty acids or derivatives thereof; Fats or oils
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • A61K31/122Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/06Free radical scavengers or antioxidants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D11/00Solvent extraction
    • B01D11/04Solvent extraction of solutions which are liquid
    • B01D11/0492Applications, solvents used

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Inorganic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Mycology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

本发明公开了一种水溶性虾青素产品及其制备方法。所述水溶性虾青素产品由虾青素、乳清蛋白、乙基纤维素组成,虾青素含量高于60%,产品颗粒尺寸为微米级。所述制备方法包括如下步骤:将虾青素醇溶液、乙基纤维素醇溶液、乳清溶液按一定比例经分批混合、均质乳化、二次乳化、低温沉降、过滤、低温真空蒸发、喷雾冷冻干燥等处理,制备得到水溶性虾青素。本发明技术有效提高虾青素的水溶性和稳定性,增加虾青素的适用范围,本发明广泛适用于食品、保健品和医药等多个领域。The invention discloses a water-soluble astaxanthin product and a preparation method thereof. The water-soluble astaxanthin product is composed of astaxanthin, whey protein and ethyl cellulose, the content of astaxanthin is higher than 60%, and the particle size of the product is micron. The preparation method comprises the following steps: mixing astaxanthin alcohol solution, ethyl cellulose alcohol solution and whey solution in batches in a certain proportion, homogeneous emulsification, secondary emulsification, low temperature sedimentation, filtration, low temperature vacuum evaporation, The water-soluble astaxanthin is prepared by treatment such as spray freeze-drying. The technology of the present invention effectively improves the water solubility and stability of astaxanthin, and increases the scope of application of astaxanthin.

Description

一种水溶性虾青素产品及其制备方法A kind of water-soluble astaxanthin product and preparation method thereof

技术领域technical field

本发明涉及海洋营养素水溶性技术领域,具体涉及一种水溶性虾青素产品及其制备方法。The invention relates to the technical field of water-soluble marine nutrients, in particular to a water-soluble astaxanthin product and a preparation method thereof.

背景技术Background technique

虾青素(3,3′-二羟基-4,4′-二酮基-β,β′-胡萝卜素)是一种脂溶性类胡萝卜色素,分子式为C40H52O4,相对分子质量596.86,不溶于水,易溶于乙醇、丙酮、乙醚和氯仿等大部分有机溶剂。虾青素主要存在于微藻、酵母、鳟鱼、磷虾、虾和小龙虾中,并且雨生红球藻是天然虾青素的丰富来源,虾青素含量高达干物质的6%,被看作天然虾青素的“浓缩品”。Astaxanthin (3,3′-dihydroxy-4,4′-diketo-β,β′-carotene) is a fat-soluble carotenoid with a molecular formula of C40H52O4 and a relative molecular mass of 596.86, insoluble in water , soluble in most organic solvents such as ethanol, acetone, ether and chloroform. Astaxanthin is mainly found in microalgae, yeast, trout, krill, shrimp and crayfish, and Haematococcus pluvialis is a rich source of natural astaxanthin, the content of astaxanthin is as high as 6% of dry matter, which is Considered a "concentrate" of natural astaxanthin.

天然虾青素是一种有效的强抗氧化剂,具有很强的抗氧化性和有效清除体内自由基,防止组织、细胞和DNA被氧化损伤,因而虾青素具有抗氧化、提高免疫力,预防肿瘤、预防心血管疾病和维护眼睛等诸多生理功能,使其逐渐应用于医药、食品、保健品和化妆品等行业且应用前景广阔。Natural astaxanthin is an effective strong antioxidant with strong antioxidant properties and can effectively scavenge free radicals in the body to prevent oxidative damage to tissues, cells and DNA. Therefore, astaxanthin has antioxidant properties, improves immunity, prevents Many physiological functions such as tumor, prevention of cardiovascular disease and maintenance of eyes, etc., make it gradually used in medicine, food, health care products and cosmetics and other industries and have broad application prospects.

虾青素分子结构中具有高度不饱和的共轭双链存在,使其极易被光照、氧气、高温和紫外线照射等发生降解氧化,影响虾青素的稳定性。虾青素难溶于水的性质,使其生物利用度低。可以通过微球技术提高虾青素的水溶性和稳定性。载药微球是指活性成分溶解或者被吸附在高分子基质中形成的微米级球状实体。微球不仅保护芯材活性成分免受环境如氧气、高温和pH等因素的影响,还能提高活性成分的分散性,掩盖不良气味及控制释放,从而提高虾青素产品的商业价值。Astaxanthin has a highly unsaturated conjugated double chain in its molecular structure, which makes it easy to be degraded and oxidized by light, oxygen, high temperature and ultraviolet radiation, which affects the stability of astaxanthin. The insoluble nature of astaxanthin in water makes its bioavailability low. The water solubility and stability of astaxanthin can be improved by microsphere technology. Drug-loaded microspheres refer to micron-sized spherical entities formed by dissolving or adsorbing active ingredients in a polymer matrix. The microspheres not only protect the active ingredients of the core material from environmental factors such as oxygen, high temperature and pH, but also improve the dispersibility of the active ingredients, mask unpleasant odors and control the release, thereby enhancing the commercial value of astaxanthin products.

目前,国内外学者主要通过结构改良、乳化或微胶囊化等方法对虾青素水溶性的改善进行研究。其中,结构改良是通过在虾青素上连接亲水性基团来提高水溶性,公开号为CN105646869A的中国专利公开了水溶性虾青素衍生物及其制备方法,该发明利用虾青素、琥珀酸酐和聚乙二醇(PEG)制备虾青素琥珀酸二酯——PEG衍生物,但这种制备方法在有机溶剂体系中进行,有机溶剂残留,存在安全隐患。公开号CN101297691A的中国专利公开了稳定的水溶性类胡萝卜素干粉的制备方法,该发明将虾青素溶解于丙酮后,再与高于其5倍质量的S-40、阿拉伯胶、β-环糊精、黄原胶和普鲁兰多糖等多种表面活性剂和稳定剂混合,并经喷雾干燥进行制备。该方法主要通过添加稳定剂使虾青素在水中分散,过量使用添加剂不适于加工食品,且存在有机溶剂残留的安全隐患;此外,虾青素在高于100℃时会降解,该发明中使用的喷雾干燥条件不利于虾青素的稳定。公开文献《Physicochemicalproperties of whey-protein-stabilized astaxanthin nanodispersion and itstransport via a Caco-2monolayer》报道了利用分离乳清蛋白作为稳定剂制备虾青素纳米分散体,但其采用的溶剂为丙酮/二氯甲烷混合体系,存在安全隐患,且产品类型不便于运输和保存。公开文献《Astaxanthin from Phaffia rhodozyma:Microencapsulationwith carboxymethyl cellulose sodium and microcrystalline cellulose andeffects of microencapsulated astaxanthin on yogurt properties》报道了利用羧甲基纤维素钠和微晶纤维素作为壁材,通过微胶囊技术来提高虾青素的水溶性,制备产品虾青素含量低,颗粒不均一,应用于食品中容易分层。公开文献《Encapsulation of anastaxanthin-containing lipid extract from shrimp waste by complexcoacervation using a novel gelatinecashew gum complex》报道了利用明胶和腰果胶复合物作为壁材,通过复合凝聚法来提高虾青素的溶解度,但这种制备方法得到的虾青素产品溶解度仅为28.6%,虾青素水溶性低。公开文献《Potato protein-based carriersfor enhancing bioavailability of astaxanthin》报道了用马铃薯蛋白作为载体来改善虾青素的溶解性,但这种制备方法需要对马铃薯蛋白溶液透析一周,耗时长,生产过程也较复杂。因此,有必要研究可行性高、简单有效的方法用于提高虾青素的水溶性。At present, scholars at home and abroad mainly study the improvement of the water solubility of astaxanthin by means of structural improvement, emulsification or microencapsulation. Among them, the structural improvement is to improve water solubility by connecting hydrophilic groups on astaxanthin. The Chinese Patent Publication No. CN105646869A discloses water-soluble astaxanthin derivatives and preparation methods thereof. The invention utilizes astaxanthin, Succinic anhydride and polyethylene glycol (PEG) are used to prepare astaxanthin succinic acid diester, a PEG derivative, but this preparation method is carried out in an organic solvent system, and the organic solvent remains, which has potential safety hazards. The Chinese patent of publication number CN101297691A discloses the preparation method of stable water-soluble carotenoid dry powder. In the invention, after astaxanthin is dissolved in acetone, it is mixed with S-40, gum arabic, β-ring 5 times higher than its mass. Various surfactants and stabilizers such as dextrin, xanthan gum and pullulan are mixed and prepared by spray drying. This method mainly disperses astaxanthin in water by adding a stabilizer. Excessive use of additives is not suitable for processed food, and there is a potential safety hazard of organic solvent residues; The spray drying conditions are not conducive to the stabilization of astaxanthin. The public document "Physicochemical properties of whey-protein-stabilized astaxanthin nanodispersion and its transport via a Caco-2monolayer" reported the preparation of astaxanthin nanodispersion by using isolated whey protein as a stabilizer, but the solvent used was acetone/dichloromethane mixed system, there are potential safety hazards, and the product type is not convenient for transportation and storage. The public document "Astaxanthin from Phaffia rhodozyma: Microencapsulation with carboxymethyl cellulose sodium and microcrystalline cellulose and effects of microencapsulated astaxanthin on yogurt properties" reported the use of sodium carboxymethyl cellulose and microcrystalline cellulose as wall materials to improve astaxanthin by microencapsulation technology High water solubility, low content of astaxanthin in the prepared product, uneven particles, and easy stratification when applied to food. The open document "Encapsulation of anastaxanthin-containing lipid extract from shrimp waste by complexcoacervation using a novel gelatinecashew gum complex" reported the use of gelatin and cashew gum complex as a wall material to improve the solubility of astaxanthin by complex coacervation, but this The solubility of the astaxanthin product obtained by the preparation method is only 28.6 percent, and the water-solubility of the astaxanthin is low. The open document "Potato protein-based carriers for enhancing bioavailability of astaxanthin" reported using potato protein as a carrier to improve the solubility of astaxanthin, but this preparation method requires dialysis of the potato protein solution for a week, which is time-consuming and complicated in the production process. . Therefore, it is necessary to study a highly feasible, simple and effective method for improving the water solubility of astaxanthin.

发明内容SUMMARY OF THE INVENTION

针对现有技术存在的问题,本发明的目的是提供了一种水溶性虾青素产品及其制备方法。In view of the problems existing in the prior art, the purpose of the present invention is to provide a water-soluble astaxanthin product and a preparation method thereof.

本发明解决上述技术问题的技术方案如下:The technical scheme that the present invention solves the above-mentioned technical problems is as follows:

一种水溶性虾青素产品及其制备方法,其特征在于:产品由以下质量百分比含量的原料:虾青素含量60%~80%,乳清蛋白含量20%~30%,乙基纤维素10%~20%组成;制备方法包括如下步骤:A water-soluble astaxanthin product and a preparation method thereof, characterized in that: the product is composed of the following raw materials by mass percentage: astaxanthin content of 60% to 80%, whey protein content of 20% to 30%, ethyl cellulose 10% to 20% composition; the preparation method includes the following steps:

1.虾青素醇溶液和乙基纤维素醇溶液按1:1~2:3混合,经1000rpm~1500rpm转速搅拌10~20min均匀后,以1mL/s速率注入高浓度乳清溶液,持续以1000rpm~1500rpm转速均质乳化5~10min,得到油包水乳液;其中:所述虾青素醇溶液为将虾青素加入无水乙醇,经搅拌溶解,配制成质量体积比为、3%~5%的虾青素醇溶液;所述乙基纤维素醇溶液是将乙基纤维素加入无水乙醇,经搅拌4~5h,配制成质量体积为0.5~1%的乙基纤维素醇溶液;所述高度乳清溶液为将乳清蛋白粉溶于蒸馏水中,搅拌0.5~1h,配制成质量体积比为2%~3%的乳清溶液;所述高度乳清溶液的体积为10~20mL;1. Mix astaxanthin alcohol solution and ethyl cellulose alcohol solution at a ratio of 1:1 to 2:3. After stirring at 1000 rpm to 1500 rpm for 10 to 20 minutes, inject high-concentration whey solution at a rate of 1 mL/s. 1000rpm~1500rpm rotating speed is homogeneously emulsified for 5~10min to obtain a water-in-oil emulsion; wherein: the astaxanthin alcohol solution is to add astaxanthin into absolute ethanol, stir and dissolve, and prepare a mass-volume ratio of 3%~ 5% astaxanthin alcohol solution; the ethyl cellulose alcohol solution is prepared by adding ethyl cellulose into anhydrous ethanol, and stirring for 4-5 hours to prepare a mass-volume 0.5-1% ethyl cellulose alcohol solution The high whey solution is prepared by dissolving whey protein powder in distilled water, stirring for 0.5 to 1 h, and preparing a whey solution with a mass-to-volume ratio of 2% to 3%; the volume of the high whey solution is 10~10%. 20mL;

2.将低浓度乳清溶液以35~40mL/s速率注入步骤1制得的油包水乳液,同时以1000~1500rpm转速混合,二次乳化5~20min,得到水包油乳液;低浓度乳清溶液是将乳清蛋白粉溶于蒸馏水中,搅拌0.5~1h,配制成质量体积比为0.1~0.3%的乳清溶液;所述低浓度乳清溶液的体积为180~190mL;水包油乳液中油水相体积比为1:1.9~1:2.1;2. Inject the low-concentration whey solution into the water-in-oil emulsion prepared in step 1 at a rate of 35-40 mL/s, mix at a rotational speed of 1000-1500 rpm, and emulsify twice for 5-20 minutes to obtain an oil-in-water emulsion; The whey solution is to dissolve the whey protein powder in distilled water, stir for 0.5-1 h, and prepare a whey solution with a mass-volume ratio of 0.1-0.3%; the volume of the low-concentration whey solution is 180-190 mL; oil-in-water The volume ratio of oil-water phase in the emulsion is 1:1.9~1:2.1;

3.将步骤2制得的水包油乳液于4℃避光静置12~24h,沉淀过量添加的乙基纤维素和虾青素,经200目纱网筛滤后,经低温真空蒸发去除乙醇,旋蒸温度为35~40℃,得到虾青素水溶液;将虾青素水溶液进行喷雾冷冻干燥,喷雾冷冻干燥的条件为冷凝温度-40℃,于30℃条件下干燥6~8h,制得水溶性虾青素产品。产品中虾青素含量和溶解度分别为62.7~75.9%和42.6~56%。3. Let the oil-in-water emulsion prepared in step 2 stand in the dark at 4°C for 12 to 24 hours to precipitate excess ethyl cellulose and astaxanthin, filter through a 200-mesh gauze, and then remove by low-temperature vacuum evaporation Ethanol, rotary evaporation temperature of 35 ~ 40 ℃, to obtain astaxanthin aqueous solution; spray freeze drying of astaxanthin aqueous solution, the conditions of spray freeze drying are condensation temperature -40 ℃, drying at 30 ℃ for 6 ~ 8 hours, the preparation A water-soluble astaxanthin product was obtained. The content and solubility of astaxanthin in the product are 62.7-75.9% and 42.6-56% respectively.

上述乳清溶液由乳清蛋白按0.5%~3%的质量体积比加入至一定体积的蒸馏水后,经搅拌0.5~1.0h,配成乳清溶液。The whey solution is prepared by adding whey protein to a certain volume of distilled water at a mass volume ratio of 0.5% to 3%, and stirring for 0.5 to 1.0 hours to prepare a whey solution.

上述水溶性虾青素含虾青素63%,溶解度56%,水溶性虾青素的颗粒尺寸范围280nm~320nm。The above water-soluble astaxanthin contains 63% astaxanthin, has a solubility of 56%, and the particle size of the water-soluble astaxanthin ranges from 280 nm to 320 nm.

本发明所用的乙基纤维素从上海麦克林生化科技有限公司购买,其粘度为45~55mPa.s;本发明所用的虾青素含量为95%。The ethyl cellulose used in the present invention is purchased from Shanghai McLean Biochemical Technology Co., Ltd., and its viscosity is 45-55 mPa.s; the content of astaxanthin used in the present invention is 95%.

与现有技术相比,本发明具有以下有益效果:Compared with the prior art, the present invention has the following beneficial effects:

1.本发明提供的一种水溶性虾青素产品及其制备方法,采用两次乳化法制备乙基纤维素-虾青素乳液,减小乙基纤维素在富水相乳液中聚集,从而减小乳液粒径;将乳清蛋白溶液作乳化剂,提高虾青素的分散性和水溶性;喷雾冷冻干燥在低温条件下保持虾青素的功能活性。1. A kind of water-soluble astaxanthin product provided by the invention and preparation method thereof, adopt twice emulsification method to prepare ethyl cellulose-astaxanthin emulsion, reduce the aggregation of ethyl cellulose in the rich water phase emulsion, thereby Reduce the particle size of the emulsion; use the whey protein solution as an emulsifier to improve the dispersibility and water solubility of astaxanthin; spray freeze drying to maintain the functional activity of astaxanthin under low temperature conditions.

2.本发明方法具有可行性强、操作工艺简单、使用食品级有机溶剂、无安全隐患的优点,水溶性虾青素含虾青素62.7%~76.9%,溶解度为42.6%~56%,原料虾青素溶解度11.81%,与原料虾青素相比,水溶性虾青素溶解度明显提高,而且保持虾青素的生物活性,可广泛应用于食品、保健品和医药行业中。2. The method of the present invention has the advantages of strong feasibility, simple operation process, use of food-grade organic solvents, and no potential safety hazards. The solubility of astaxanthin is 11.81%. Compared with the raw material astaxanthin, the solubility of water-soluble astaxanthin is significantly improved, and the biological activity of astaxanthin is maintained. It can be widely used in food, health products and pharmaceutical industries.

附图说明Description of drawings

图1为本发明实施例1所得的虾青素和水溶性虾青素的粒度分布图。1 is a particle size distribution diagram of astaxanthin and water-soluble astaxanthin obtained in Example 1 of the present invention.

图2为本发明实施例1所得的水溶性虾青素产品图。Figure 2 is a product diagram of the water-soluble astaxanthin obtained in Example 1 of the present invention.

图3为本发明实施例1所得的水溶性虾青素在水溶液的分散性图。Fig. 3 is a dispersibility diagram of the water-soluble astaxanthin obtained in Example 1 of the present invention in an aqueous solution.

图4为本发明实施例1所得水溶性虾青素在pH2~pH8水溶液中时贮存3周后的Zeta等电位。4 is the Zeta equipotentiality of the water-soluble astaxanthin obtained in Example 1 of the present invention after storage for 3 weeks in an aqueous solution of pH 2 to pH 8 .

具体实施方式Detailed ways

通过以下实施例和附图对本发明作进一步的说明。The present invention will be further illustrated by the following examples and accompanying drawings.

实施例1Example 1

一种水溶性虾青素产品及其制备方法,包括如下步骤:A water-soluble astaxanthin product and a preparation method thereof, comprising the steps:

1.将虾青素醇溶液和的乙基纤维素醇溶液按1:1混合,经1500rpm转速搅拌20min均匀后,以1mL/s速率注入10mL高浓度乳清溶液(质量体积为2%),持续以1500rpm转速均质乳化10min,得到油包水乳液;其中,虾青素醇溶液是将虾青素加入无水乙醇,经搅拌溶解,配成质量体积为5%的虾青素醇溶液;乙基纤维素醇溶液是将乙基纤维素加入无水乙醇,经搅拌4h,配成质量体积为1%的乙基纤维素醇溶液;高浓度乳清溶液是将乳清蛋白粉溶于蒸馏水中,搅拌0.5h,配制成质量体积比为2%的乳清溶液;高浓度乳清溶液的加入体积是10mL;1. Mix the astaxanthin alcohol solution and the ethyl cellulose alcohol solution at 1:1, stir evenly for 20 minutes at 1500 rpm, and inject 10 mL of high-concentration whey solution (2% by mass by volume) at a rate of 1 mL/s, Continue to homogeneously emulsify at 1500 rpm for 10 min to obtain a water-in-oil emulsion; wherein, the astaxanthin alcohol solution is made by adding astaxanthin into absolute ethanol, stirring and dissolving, to prepare a 5% mass/volume astaxanthin alcohol solution; Ethyl cellulose alcohol solution is made by adding ethyl cellulose into absolute ethanol, and stirring for 4 hours to prepare ethyl cellulose alcohol solution with a mass volume of 1%; high-concentration whey solution is to dissolve whey protein powder in distilled water , stir for 0.5h, and prepare a whey solution with a mass-to-volume ratio of 2%; the addition volume of the high-concentration whey solution is 10mL;

2.将低浓度乳清溶液以40mL/s速率注入步骤1制得的油包水乳液,同时以1500rpm转速混合,二次乳化20min,得到水包油乳液;低浓度乳清溶液是将乳清蛋白粉溶于蒸馏水中,搅拌0.5h,配制成质量体积比为0.3%的乳清溶液;所述低浓度乳清溶液的体积为190mL;水包油乳液中油水相体积比为1:2;2. The low-concentration whey solution was injected into the water-in-oil emulsion prepared in step 1 at a rate of 40 mL/s, mixed at a speed of 1500 rpm, and emulsified for 20 minutes to obtain an oil-in-water emulsion; the low-concentration whey solution was a mixture of whey The protein powder was dissolved in distilled water, stirred for 0.5 h, and prepared into a whey solution with a mass-volume ratio of 0.3%; the volume of the low-concentration whey solution was 190 mL; the oil-water phase volume ratio in the oil-in-water emulsion was 1:2;

3.将步骤2制得的水包油乳液于4℃避光静置12h,沉淀过量添加的乙基纤维素和虾青素,经200目纱网筛滤后,经低温真空蒸发去除乙醇,旋蒸温度为37℃,得到虾青素水溶液;将虾青素水溶液进行喷雾冷冻干燥,喷雾冷冻干燥的条件为冷凝温度-40℃,于30℃条件下干燥7h,制得水溶性虾青素产品。产品中虾青素含量和溶解度分别为75.9%和56%。3. The oil-in-water emulsion prepared in step 2 was allowed to stand for 12 hours at 4°C in the dark to precipitate excess ethyl cellulose and astaxanthin. After sieving through a 200-mesh gauze, the ethanol was removed by low-temperature vacuum evaporation. The rotary evaporation temperature is 37°C to obtain astaxanthin aqueous solution; the astaxanthin aqueous solution is spray-freeze-dried, and the spray freeze-drying condition is the condensation temperature of -40°C, and dried at 30°C for 7 hours to obtain water-soluble astaxanthin product. The content and solubility of astaxanthin in the product were 75.9% and 56%, respectively.

实施例2Example 2

一种水溶性虾青素产品及其制备方法,包括如下步骤:A water-soluble astaxanthin product and a preparation method thereof, comprising the steps:

1.将虾青素醇溶液和的乙基纤维素醇溶液按2:1混合,经1500rpm转速搅拌20min均匀后,以1mL/s速率注入20mL高浓度乳清溶液(质量体积为3%),持续以1500rpm转速均质乳化10min,得到油包水乳液;其中,虾青素醇溶液是将虾青素加入无水乙醇,经搅拌溶解,配成质量体积为5%的虾青素醇溶液;乙基纤维素醇溶液是将乙基纤维素加入无水乙醇,经搅拌5h,配成质量体积为0.5%的乙基纤维素醇溶液;高浓度乳清溶液是将乳清蛋白粉溶于蒸馏水中,搅拌0.5h,配制成质量体积比为2.5%的乳清溶液;高浓度乳清溶液的加入体积是15mL;1. Mix the astaxanthin alcohol solution and the ethyl cellulose alcohol solution at a ratio of 2:1, stir evenly for 20 minutes at 1500 rpm, and inject 20 mL of high-concentration whey solution (3% by mass by volume) at a rate of 1 mL/s, Continue to homogeneously emulsify at 1500 rpm for 10 min to obtain a water-in-oil emulsion; wherein, the astaxanthin alcohol solution is made by adding astaxanthin into absolute ethanol, stirring and dissolving, to prepare a 5% mass/volume astaxanthin alcohol solution; Ethyl cellulose alcohol solution is made by adding ethyl cellulose into absolute ethanol, and stirring for 5 hours to prepare ethyl cellulose alcohol solution with a mass volume of 0.5%; high-concentration whey solution is whey protein powder dissolved in distilled water , stir for 0.5h, and prepare a whey solution with a mass-to-volume ratio of 2.5%; the added volume of the high-concentration whey solution is 15mL;

2.将低浓度乳清溶液以40mL/s速率注入步骤1制得的油包水乳液,同时以1500rpm转速混合,二次乳化10min,得到水包油乳液;低浓度乳清溶液是将乳清蛋白粉溶于蒸馏水中,搅拌0.5h,配制成质量体积比为0.3%的乳清溶液;所述低浓度乳清溶液的体积为190mL;水包油乳液中油水相体积比为1:2.1;2. Inject the low-concentration whey solution into the water-in-oil emulsion prepared in step 1 at a rate of 40 mL/s, mix at 1500 rpm, and emulsify twice for 10 minutes to obtain an oil-in-water emulsion; the low-concentration whey solution is a The protein powder was dissolved in distilled water, stirred for 0.5 h, and prepared into a whey solution with a mass-volume ratio of 0.3%; the volume of the low-concentration whey solution was 190 mL; the oil-water phase volume ratio in the oil-in-water emulsion was 1:2.1;

3.将步骤2制得的水包油乳液于4℃避光静置24h,沉淀过量添加的乙基纤维素和虾青素,经200目纱网筛滤后,经低温真空蒸发去除乙醇,旋蒸温度为40℃,得到虾青素水溶液;将虾青素水溶液进行喷雾冷冻干燥,喷雾冷冻干燥的条件为冷凝温度-40℃,于30℃条件下干燥8h,制得水溶性虾青素产品。产品中虾青素含量和溶解度分别为68.7%和53.8%。3. The oil-in-water emulsion prepared in step 2 was allowed to stand for 24 hours at 4°C in the dark to precipitate the excess added ethyl cellulose and astaxanthin. After sieving through a 200-mesh gauze, the ethanol was removed by low-temperature vacuum evaporation. The temperature of rotary evaporation is 40°C to obtain an aqueous solution of astaxanthin; the aqueous solution of astaxanthin is subjected to spray freeze-drying, and the conditions of spray freeze-drying are condensation temperature -40°C, and dried at 30°C for 8 hours to obtain water-soluble astaxanthin product. The content and solubility of astaxanthin in the product were 68.7% and 53.8%, respectively.

实施例3Example 3

一种水溶性虾青素产品及其制备方法,包括如下步骤:A water-soluble astaxanthin product and a preparation method thereof, comprising the steps:

1.将虾青素醇溶液和的乙基纤维素醇溶液按2:3混合,经1000rpm转速搅拌10min均匀后,以1mL/s速率注入10mL高浓度乳清溶液(质量体积为2%),持续以1000rpm转速均质乳化5min,得到油包水乳液;其中,虾青素醇溶液是将虾青素加入无水乙醇,经搅拌溶解,配成质量体积为3%的虾青素醇溶液;乙基纤维素醇溶液是将乙基纤维素加入无水乙醇,经搅拌4h,配成质量体积为0.5%的乙基纤维素醇溶液;高浓度乳清溶液是将乳清蛋白粉溶于蒸馏水中,搅拌1h,配制成质量体积比为3%的乳清溶液;高浓度乳清溶液的加入体积是20mL;1. Mix the astaxanthin alcohol solution and the ethyl cellulose alcohol solution at a ratio of 2:3, stir evenly for 10 minutes at 1000 rpm, and then inject 10 mL of high-concentration whey solution (2% by mass by volume) at a rate of 1 mL/s, Continue to homogeneously emulsify at 1000rpm for 5min to obtain a water-in-oil emulsion; wherein, the astaxanthin alcohol solution is obtained by adding astaxanthin into absolute ethanol, and stirring and dissolving to prepare a 3% mass/volume astaxanthin alcohol solution; Ethyl cellulose alcohol solution is made by adding ethyl cellulose into absolute ethanol, and stirring for 4 hours to prepare a 0.5% ethyl cellulose alcohol solution by mass and volume; high-concentration whey solution is a solution of whey protein powder dissolved in distilled water , stir for 1h, and prepare a whey solution with a mass-to-volume ratio of 3%; the added volume of the high-concentration whey solution is 20mL;

2.将低浓度乳清溶液以35mL/s速率注入步骤1制得的油包水乳液,同时以1000rpm转速混合,二次乳化5min,得到水包油乳液;低浓度乳清溶液是将乳清蛋白粉溶于蒸馏水中,搅拌1h,配制成质量体积比为0.1%的乳清溶液;所述低浓度乳清溶液的体积为180mL;水包油乳液中油水相体积比为1:1.9;2. Inject the low-concentration whey solution into the water-in-oil emulsion prepared in step 1 at a rate of 35 mL/s, mix at a speed of 1000 rpm, and emulsify twice for 5 minutes to obtain an oil-in-water emulsion; the low-concentration whey solution is a mixture of whey The protein powder was dissolved in distilled water, stirred for 1 hour, and prepared into a whey solution with a mass-volume ratio of 0.1%; the volume of the low-concentration whey solution was 180 mL; the oil-water phase volume ratio in the oil-in-water emulsion was 1:1.9;

3.将步骤2制得的水包油乳液于4℃避光静置12h,沉淀过量添加的乙基纤维素和虾青素,经200目纱网筛滤后,经低温真空蒸发去除乙醇,旋蒸温度为35℃,得到虾青素水溶液;将虾青素水溶液进行喷雾冷冻干燥,喷雾冷冻干燥的条件为冷凝温度-40℃,于30℃条件下干燥6h,制得水溶性虾青素产品。产品中虾青素含量和溶解度分别为62.7%和42.6%。3. The oil-in-water emulsion prepared in step 2 was allowed to stand for 12 hours at 4°C in the dark to precipitate excess ethyl cellulose and astaxanthin. After sieving through a 200-mesh gauze, the ethanol was removed by low-temperature vacuum evaporation. The temperature of rotary evaporation is 35°C to obtain an aqueous solution of astaxanthin; the aqueous solution of astaxanthin is spray-freeze-dried, and the conditions for spray-freeze-drying are the condensation temperature of -40°C, and the water-soluble astaxanthin is obtained by drying at 30°C for 6 hours. product. The content and solubility of astaxanthin in the product were 62.7% and 42.6%, respectively.

实施例1制备的虾青素醇溶液、水溶性虾青素的平均粒径分别为231.7±1.88nm和307.30±11.36nm,具体粒度分布见图1。The average particle diameters of the astaxanthin alcohol solution and the water-soluble astaxanthin prepared in Example 1 are 231.7±1.88nm and 307.30±11.36nm respectively, and the specific particle size distribution is shown in FIG. 1 .

实施例1制备的水溶性虾青素产品见图2。The water-soluble astaxanthin product prepared in Example 1 is shown in Figure 2.

实施例1制备的水溶性虾青素和原料虾青素粉末在水溶液中的分散性见图3。The dispersibility of the water-soluble astaxanthin prepared in Example 1 and the raw material astaxanthin powder in the aqueous solution is shown in Figure 3.

实施例1制备水溶性虾青素在pH2-8范围水溶液贮存3周后水溶性虾青素Zeta电位图见图4。按照表面电荷绝对值≥30mV溶液体系稳定,水溶性虾青素溶液稳定性良好。Example 1 Preparation of water-soluble astaxanthin The Zeta potential diagram of water-soluble astaxanthin after storage in an aqueous solution in the pH range of 2-8 for 3 weeks is shown in FIG. 4 . According to the absolute value of surface charge ≥30mV, the solution system is stable, and the water-soluble astaxanthin solution has good stability.

Claims (3)

1.一种水溶性虾青素产品及其制备方法,其特征在于:产品由以下质量百分比含量的原料:虾青素含量60%~80%,乳清蛋白含量20%~30%,乙基纤维素10%~20%组成;制备方法包括如下步骤:1. a water-soluble astaxanthin product and preparation method thereof, is characterized in that: product is made up of the raw material of following mass percentage content: astaxanthin content 60%~80%, whey protein content 20%~30%, ethyl acetate The composition of cellulose is 10% to 20%; the preparation method includes the following steps: (1)虾青素醇溶液和乙基纤维素醇溶液按1:1~2:3混合,经1000rpm~1500rpm转速搅拌10~20min均匀后,以1mL/s速率注入高浓度乳清溶液,持续以1000rpm~1500rpm转速均质乳化5~10min,得到油包水乳液;其中:所述虾青素醇溶液为将虾青素加入无水乙醇,经搅拌溶解,配制成质量体积比为3%~5%的虾青素醇溶液;所述乙基纤维素醇溶液是将乙基纤维素加入无水乙醇,经搅拌4~5h,配制成质量体积为0.5~1%的乙基纤维素醇溶液;所述高度乳清溶液为将乳清蛋白粉溶于蒸馏水中,搅拌0.5~1h,配制成质量体积比为2%~3%的乳清溶液;所述高浓度乳清溶液的体积为10~20mL;(1) Mix astaxanthin alcohol solution and ethyl cellulose alcohol solution at a ratio of 1:1 to 2:3. After stirring at 1000 rpm to 1500 rpm for 10 to 20 minutes, inject high-concentration whey solution at a rate of 1 mL/s for a continuous period of time. Homogeneous emulsification at 1000rpm~1500rpm rotating speed for 5~10min to obtain a water-in-oil emulsion; wherein: the astaxanthin alcohol solution is made by adding astaxanthin into anhydrous ethanol, stirring and dissolving to prepare a mass-volume ratio of 3%~ 5% astaxanthin alcohol solution; the ethyl cellulose alcohol solution is prepared by adding ethyl cellulose into anhydrous ethanol, and stirring for 4-5 hours to prepare a mass-volume 0.5-1% ethyl cellulose alcohol solution The high-density whey solution is prepared by dissolving whey protein powder in distilled water, stirring for 0.5-1 h, and preparing a whey solution with a mass-volume ratio of 2%-3%; the volume of the high-concentration whey solution is 10 ~20mL; (2)将低浓度乳清溶液以35~40mL/s速率注入步骤(1)制得的油包水乳液,同时以1000~1500rpm转速混合,二次乳化5~20min,得到水包油乳液;低浓度乳清溶液是将乳清蛋白粉溶于蒸馏水中,搅拌0.5~1h,配制成质量体积比为0.1~0.3%的乳清溶液;所述低浓度乳清溶液的体积为180~190mL;水包油乳液中油水相体积比为1:1.9~1:2.1;(2) injecting the low-concentration whey solution into the water-in-oil emulsion prepared in step (1) at a rate of 35-40 mL/s, mixing at a rotating speed of 1000-1500 rpm simultaneously, and emulsification for 5-20 min for the second time to obtain an oil-in-water emulsion; The low-concentration whey solution is to dissolve whey protein powder in distilled water, stir for 0.5-1 h, and prepare a whey solution with a mass-volume ratio of 0.1-0.3%; the volume of the low-concentration whey solution is 180-190 mL; The volume ratio of oil-water phase in the oil-in-water emulsion is 1:1.9~1:2.1; (3)将步骤(2)制得的水包油乳液于4℃避光静置12~24h,沉淀过量添加的乙基纤维素和虾青素,经200目纱网筛滤后,经低温真空蒸发去除乙醇,旋蒸温度为35~40℃,得到虾青素水溶液;将虾青素水溶液进行喷雾冷冻干燥,喷雾冷冻干燥的条件为冷凝温度-40℃,于30℃条件下干燥6~8h,制得水溶性虾青素产品,产品中虾青素含量和溶解度分别为62.7~75.9%和42.6~56%。(3) The oil-in-water emulsion obtained in step (2) was allowed to stand in the dark at 4°C for 12 to 24 hours to precipitate excess ethyl cellulose and astaxanthin. After sieving through a 200-mesh gauze, The ethanol is removed by vacuum evaporation, and the rotary evaporation temperature is 35~40 ℃ to obtain the astaxanthin aqueous solution; the astaxanthin aqueous solution is spray-freeze-dried, and the condition of the spray freeze-drying is the condensation temperature of -40 ℃, and dried at 30 ℃ for 6~ 8h, a water-soluble astaxanthin product was prepared, and the content and solubility of astaxanthin in the product were 62.7-75.9% and 42.6-56%, respectively. 2.根据权利要求1所述一种水溶性虾青素产品及其制备方法,其特征在于,所述乳清溶液由乳清蛋白按0.5%~3%的质量体积比加入至一定体积的蒸馏水后,经搅拌0.5~1.0h,配制成乳清溶液。2. a kind of water-soluble astaxanthin product and preparation method thereof according to claim 1, is characterized in that, described whey solution is added to the distilled water of certain volume by whey protein by the mass volume ratio of 0.5%~3% After stirring for 0.5-1.0 h, the whey solution is prepared. 3.根据权利要求1所述的一种水溶性虾青素产品及其制备方法,其特征在于,所述水溶性虾青素含虾青素63%,溶解度56%,水溶性虾青素的颗粒尺寸范围280nm~320nm。3. a kind of water-soluble astaxanthin product and preparation method thereof according to claim 1, is characterized in that, described water-soluble astaxanthin contains astaxanthin 63%, solubility 56%, water-soluble astaxanthin The particle size ranges from 280nm to 320nm.
CN202010097080.2A 2020-02-17 2020-02-17 Water-soluble astaxanthin product and preparation method thereof Active CN111296729B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010097080.2A CN111296729B (en) 2020-02-17 2020-02-17 Water-soluble astaxanthin product and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010097080.2A CN111296729B (en) 2020-02-17 2020-02-17 Water-soluble astaxanthin product and preparation method thereof

Publications (2)

Publication Number Publication Date
CN111296729A true CN111296729A (en) 2020-06-19
CN111296729B CN111296729B (en) 2023-10-03

Family

ID=71152891

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010097080.2A Active CN111296729B (en) 2020-02-17 2020-02-17 Water-soluble astaxanthin product and preparation method thereof

Country Status (1)

Country Link
CN (1) CN111296729B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111793014A (en) * 2020-07-27 2020-10-20 中国海洋大学 A kind of method for preparing water-soluble astaxanthin and astaxanthin aqueous solution prepared therefrom
CN113527530A (en) * 2021-08-06 2021-10-22 青岛职业技术学院 Preparation method of water-soluble astaxanthin fucoidin ester

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1656178A (en) * 2002-05-30 2005-08-17 化尔氏制药研究公司 Oil-soluble pigment compositions
CN104839688A (en) * 2015-04-20 2015-08-19 华北制药秦皇岛有限公司 Eye care preparation and preparation method thereof
US20150320699A1 (en) * 2014-05-08 2015-11-12 Yaguang Liu Pharmaceutical Composition Containing Lutein and Antioxidant for Treating and Preventing Human Disease
CN105769820A (en) * 2016-04-08 2016-07-20 华南理工大学 Method for preparing astaxanthin sustained release microsphere preparation through supercritical elution technology
CN105832569A (en) * 2016-05-31 2016-08-10 中国农业大学 Water-dispersible transparent astaxanthin emulsion and preparation method
CN106172894A (en) * 2016-07-18 2016-12-07 马鞍山市黄池食品(集团)有限公司 A kind of astaxanthin Semen Sesami gel oil and preparation method thereof
CN108403666A (en) * 2018-03-16 2018-08-17 深圳大学 A kind of preparation method of novel astaxanthin capsule of nano
CN109198382A (en) * 2018-07-24 2019-01-15 湖北工业大学 A kind of preparation method of water soluble beta-caroten powder
CN110693945A (en) * 2019-11-27 2020-01-17 上海海洋大学 Astaxanthin self-microemulsion preparation and preparation method and application thereof

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1656178A (en) * 2002-05-30 2005-08-17 化尔氏制药研究公司 Oil-soluble pigment compositions
US20150320699A1 (en) * 2014-05-08 2015-11-12 Yaguang Liu Pharmaceutical Composition Containing Lutein and Antioxidant for Treating and Preventing Human Disease
CN104839688A (en) * 2015-04-20 2015-08-19 华北制药秦皇岛有限公司 Eye care preparation and preparation method thereof
CN105769820A (en) * 2016-04-08 2016-07-20 华南理工大学 Method for preparing astaxanthin sustained release microsphere preparation through supercritical elution technology
CN105832569A (en) * 2016-05-31 2016-08-10 中国农业大学 Water-dispersible transparent astaxanthin emulsion and preparation method
CN106172894A (en) * 2016-07-18 2016-12-07 马鞍山市黄池食品(集团)有限公司 A kind of astaxanthin Semen Sesami gel oil and preparation method thereof
CN108403666A (en) * 2018-03-16 2018-08-17 深圳大学 A kind of preparation method of novel astaxanthin capsule of nano
CN109198382A (en) * 2018-07-24 2019-01-15 湖北工业大学 A kind of preparation method of water soluble beta-caroten powder
CN110693945A (en) * 2019-11-27 2020-01-17 上海海洋大学 Astaxanthin self-microemulsion preparation and preparation method and application thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
ACTIVITYDIEGO F. TIRADOA,等: "Astaxanthin encapsulation in ethyl cellulose carriers by continuoussupercritical emulsions extraction: A study on particle size,encapsulation efficiency, release profile and antioxidant activity", 《THE JOURNAL OF SUPERCRITICAL FLUIDS》 *
SENSOR RESEARCH UNIT,等: "Preventing the thermal degradation of astaxanthin through nanoencapsulation", 《INTERNATIONAL JOURNAL OF PHARMACEUTICS》 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111793014A (en) * 2020-07-27 2020-10-20 中国海洋大学 A kind of method for preparing water-soluble astaxanthin and astaxanthin aqueous solution prepared therefrom
CN111793014B (en) * 2020-07-27 2021-07-13 中国海洋大学 A kind of method for preparing water-soluble astaxanthin and astaxanthin aqueous solution prepared therefrom
CN113527530A (en) * 2021-08-06 2021-10-22 青岛职业技术学院 Preparation method of water-soluble astaxanthin fucoidin ester
CN113527530B (en) * 2021-08-06 2022-04-29 青岛职业技术学院 Preparation method of water-soluble astaxanthin fucoidin ester

Also Published As

Publication number Publication date
CN111296729B (en) 2023-10-03

Similar Documents

Publication Publication Date Title
CN105902401B (en) A kind of method preparing H- aggressiveness or J- aggressiveness astaxanthin polymer nanometer disperse systems and application
CN108403666A (en) A kind of preparation method of novel astaxanthin capsule of nano
Guan et al. Water-dispersible astaxanthin-rich nanopowder: preparation, oral safety and antioxidant activity in vivo
CN105726482A (en) Xanthophyll nano-liposome and preparation method thereof
CN111296729B (en) Water-soluble astaxanthin product and preparation method thereof
CN104337851A (en) Preparation method of oleum fructus bruceae nano structure lipid carrier and freeze-dried powder thereof
CN1698901A (en) Chitosan or its derivative as drug carrier for carrying red sage root extract
CN115364054B (en) Colon targeting oil-in-water Pickering emulsion based on shellac nano particles and chitosan and preparation and application thereof
CN109646425B (en) Preparation method and application of H1, H2 or J-type astaxanthin aggregate water dispersion system
CN101455645A (en) Preparation method of medicine microspheres using plant soy protein as carrier
CN114948880B (en) Preparation method of caffeic acid phenethyl ester nano stable slow release formulation
JP2022545594A (en) Method for preparing water-soluble astaxanthin complex and astaxanthin aqueous solution prepared thereby
CN113797177B (en) Quercetin oral sustained-release preparation modified by ionic emulsifier chitosan nanoparticles and preparation method thereof
Kou et al. Biodegradable materials as nanocarriers for drugs and nutrients
CN113244190A (en) Astaxanthin long-acting nano preparation prepared by micelle template method and preparation method thereof
CN110251487B (en) Preparation method and application of prolamin nanoparticles for improving docetaxel drug loading and oral bioavailability
CN109078184A (en) Load double medicine nano particles and the preparation method and application thereof
CN102048702B (en) A kind of bifendate nano crystal preparation and preparation method thereof
CN111567805A (en) Water-soluble haematococcus pluvialis astaxanthin soft capsule and preparation method thereof
CN1565433A (en) Hypocrellin water-soluble nanogranule and its uses
CN103432083A (en) Preparation process for glycyrrhizic acid-mediated hydroxycamptothecine albumin liver cancer targeting nanoparticle lyophilized powder
CN104434824A (en) Method for preparing xanthophylls solid dispersion
CN114796511A (en) Mixed solubilizer and preparation method thereof
RU2386446C1 (en) Method for preparing betulin nanosuspension and/or its derivatives
CN106377566A (en) Castor oil and cyclodextrin liquid dispersing agent and preparation method thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant